ArticleContrast media & molecular imaging2022
The Clinical Diagnostic Value of F-FDG PET/CT Combined with MRI in Pancreatic Cancer.
Article in Contrast media & molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
- Extended Survival with Pancreatic Carcinosarcoma: A Case Report and Literature Review.Current oncology (Toronto, Ont.) · 2025Review
- Currently Debated Topics on Surgical Treatment of Pancreatic Ductal Adenocarcinoma: A Narrative Review on Surgical Treatment of Borderline Resectable, Locally Advanced, and Synchronous or Metachronous Oligometastatic Tumor.Journal of clinical medicine · 2023Review
- Efficacy of Staging Laparoscopy in Patients With Pancreatic Cancer: A Single Center Prospective Cohort Study.In vivo (Athens, Greece)Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreatic cancer is a common gastrointestinal tumor with increasing morbidity and mortality, and it is difficult to differentiate it from chronic mass pancreatitis. F-18-fluorodeoxyglucose positron emission tomography/computed tomography (F-FDG PET/CT) can be used for diagnosis of pancreatic cancer, staging, radiotherapy planning, evaluation of efficacy and recurrence, and differentiation from posttreatment fibrosis but the sensitivity and specificity of diagnosis of chronic pancreatitis are poor. Magnetic resonance imaging (MRI) not only shows the morphology, location, and size of organs and lesions but also has the advantages of low radiation, high soft tissue contrast, and multiparameter imaging, which can help determine the nature of occupying pancreatic lesions. In this study, the watershed algorithm (WA) was used to segment the abdominal images to extract images of pancreatic cancer cells and to compare the value of F-FDG PET/CT combined with MRI in the diagnosis of pancreatic occupying lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.